IP Library Granted Patent US 10,227,522
Granted Patent B2
US 10,227,522 · App. 15/163,722 · Granted Mar 12, 2019

Fluid efficiency for viscoelastic surfactant based fluids with nanoparticles

Inventors: Shiv Shankar Sangaru (Al-Khobar, SA); Prahlad Yadav (Jabalpur, IN); Tianping Huang (Spring, TX); Gaurav Agrawal (Dammam, SA); Mohammed Al-Rabah (Qataif, SA)
Assignee: BAKER HUGHES, A GE COMPANY, LLC
C09K8/506C09K8/5045C09K8/602C09K8/665C09K8/68E21B43/16E21B43/26C09K2208/10C09K2208/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,227,522
App. No.
15/163,722
Granted
Mar 12, 2019
Kind
B2
Abstract

A method of treating a subterranean formation penetrated by a well comprises combining an aqueous base fluid, a viscoelastic surfactant gelling agent, two or more types of the following nanoparticles: an alkaline earth metal oxide; an alkaline earth metal hydroxide; a transition metal oxide; or a transition metal hydroxide to form a treatment fluid, and pumping the treatment fluid into the well, wherein the weight ratio of the two or more types of the nanoparticles is selected such that the treatment fluid has an improved fluid efficiency as compared to an otherwise identical reference fluid except for comprising only one type of the nanoparticles selected from an alkaline earth metal oxide; an alkaline earth metal hydroxide; a transition metal oxide; and a transition metal hydroxide.

Claims (28)

1. A method of treating a subterranean formation penetrated by a well, the method comprising:

combining an aqueous base fluid, a viscoelastic surfactant gelling agent, a first nanoparticle comprising magnesium oxide, and a second nanoparticle comprising zinc oxide to form a treatment fluid, and

pumping the treatment fluid into the well,

wherein the weight ratio of the first and the second nanoparticles is selected such that the treatment fluid has an improved fluid efficiency as compared to an otherwise identical reference fluid except for comprising only one of the first and second nanoparticles; and

the weight ratio of the first nanoparticle relative to the second nanoparticle is about 2:1 to about 1:3.

2. The method of claim 1 , wherein the aqueous base fluid is a brine comprising about 5 wt. % to about 50 wt. % of a salt.

3. The method of claim 2 , wherein the brine is seawater, produced water, completion brine, or a combination thereof.

4. The method of claim 1 , wherein the sum of the weight of the first nanoparticle and the second nanoparticle is about 2 parts per weight to about 50 parts by weight per one thousand gallons of the treatment fluid.

5. The method of claim 1 , wherein the viscoelastic surfactant is present in an amount of about 2 wt. % to about 20 wt. %, based on the total weight of the treatment fluid.

6. The method of claim 1 , wherein the treatment fluid has a viscosity of about 50 to about 350 cP at 300° F. and 100 s −1 .

7. The method of claim 1 , wherein the viscoelastic surfactant gelling agent is erucamidopropyl hydroxypropyl sulfobetaine, erucamidopropyl hydroxyethyl sulfobetaine, erucamidopropyl hydroxymethyl sulfobetaine, or a combination comprising at least one of the foregoing.

8. The method of claim 1 , wherein the viscoelastic surfactant gelling agent is erucamidopropyl hydroxypropyl sulfobetaine.

9. The method of claim 1 , wherein the viscoelastic surfactant gelling agent is present in an amount of about 5 wt. % to about 15 wt. %, based on the total weight of the treatment fluid.

10. The method of claim 1 , wherein the sum of the weight of the first nanoparticle and the second nanoparticle is about 10 parts per weight to about 40 parts by weight per one thousand gallons of the treatment fluid.

11. The method of claim 1 , wherein the sum of the weight of the first nanoparticle and the second nanoparticle is about 20 parts per weight to about 30 parts by weight per one thousand gallons of the treatment fluid.

12. The method of claim 1 , wherein the treatment fluid has a viscosity of about 50 to about 350 cP at 300° F. and 100 s −1 .

13. The method of claim 1 , wherein the first nanoparticle and the second nanoparticle each independently has a particle size of about 10 nanometers to about 500nanometers.

14. The method of claim 13 , wherein the first nanoparticle and the second nanoparticle each independently has a particle size of about 20 nanometers to about 100 nanometers.

15. The method of claim 13 , wherein the first nanoparticle and the second nanoparticle each independently has a particle size of about 20 nanometers to about 40 nanometers.

16. A method of treating a subterranean formation penetrated by a well, the method comprising:

combining an aqueous base fluid, a viscoelastic surfactant gelling agent, a magnesium oxide nanoparticle, and a zinc oxide nanoparticle to form a treatment fluid, and

pumping the treatment fluid into the well,

wherein the weight ratio of the magnesium oxide nanoparticle and the zinc oxide nanoparticle is selected such that the treatment fluid has an improved fluid efficiency as compared to an otherwise identical reference fluid except for comprising only one of magnesium oxide nanoparticle and zinc oxide nanoparticle,

the magnesium oxide nanoparticle and the zinc oxide nanoparticle each independently has a particle size of about 20 nanometers to about 40 nanometers,

the sum of the weight of the magnesium oxide nanoparticle and the zinc oxide nanoparticle is about 20 parts per weight to about 30 parts by weight per one thousand gallons of the treatment fluid, and

the weight ratio of the magnesium oxide nanoparticle relative to the zinc oxide nanoparticle is about 2:1 to about 1:3.

17. The method of claim 16 , wherein the viscoelastic surfactant gelling agent is erucamidopropyl hydroxypropyl sulfobetaine, erucamidopropyl hydroxyethyl sulfobetaine, erucamidopropyl hydroxymethyl sulfobetaine, or a combination comprising at least one of the foregoing, and the viscoelastic surfactant gelling agent is present in an amount of about 2 wt. % to about 20 wt. %, based on the total weight of the treatment fluid.

18. The method of claim 16 , wherein the aqueous base fluid is a brine comprising about 15 wt. % to about 40 wt. % of a salt.

Assignments (3)
CHANGE OF NAME Recorded Mar 8, 2022
From: BAKER HUGHES, A GE COMPANY, LLC
To: BAKER HUGHES HOLDINGS LLC
Reel/Frame 059339/0130 →
CHANGE OF NAME Recorded Feb 16, 2022
From: BAKER HUGHES INCORPORATED
To: BAKER HUGHES, A GE COMPANY, LLC
Reel/Frame 059126/0517 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2016
From: SANGARU, SHIV SHANKAR; YADAV, PRAHLAD; HUANG, TIANPING; AGRAWAL, GAURAV; AL-RABAH, MOHAMMED
To: BAKER HUGHES INCORPORATED
Reel/Frame 038710/0945 →
Continuity (1)
Related Publication 20170342308A1 · Nov 30, 2017